Phase II trial of depsipeptide (NSC-630176) in colorectal cancer patients who have received either one or two prior chemotherapy regimens for metastatic or locally advanced, unresectable disease: A Southwest Oncology Group study.

被引：0
|
作者：
Whitehead, R. P.
Mccoy, S.
Wollner, I. S.
Wong, L.
Harker, W. G.
Hoff, P. M.
Gold, P. J.
Billingsley, K. G.
Blanke, C. D.
机构：
[1] Univ Texas, Med Branch, Galveston, TX 77555 USA
[2] SW Oncol Grp, Ctr Stat, Seattle, WA USA
[3] Henry Ford Hosp, Detroit, MI 48202 USA
[4] White CCOP, Temple, TX USA
[5] Utah Canc Specialists, Salt Lake City, UT USA
[6] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[7] Swedish Canc Inst, Seattle, WA USA
[8] Oregon Hlth Sci Univ, Inst Canc, Portland, OR 97201 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3598
引用
收藏
页码：170S / 170S
页数：1
相关论文
共 50 条
  • [1] Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336)
    Robert P. Whitehead
    Cathryn Rankin
    Paulo M. G. Hoff
    Philip J. Gold
    Kevin G. Billingsley
    Robert A. Chapman
    Lucas Wong
    John H. Ward
    James L. Abbruzzese
    Charles D. Blanke
    Investigational New Drugs, 2009, 27
  • [2] Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336)
    Whitehead, Robert P.
    Rankin, Cathryn
    Hoff, Paulo M. G.
    Gold, Philip J.
    Billingsley, Kevin G.
    Chapman, Robert A.
    Wong, Lucas
    Ward, John H.
    Abbruzzese, James L.
    Blanke, Charles D.
    INVESTIGATIONAL NEW DRUGS, 2009, 27 (05) : 469 - 475
  • [3] Phase II trial of R115777 (NSC #70818) in patients with advanced colorectal cancer: A Southwest Oncology Group study
    Whitehead, RP
    McCoy, S
    Macdonald, JS
    Rivkin, SE
    Neubauer, MA
    Dakhil, SR
    Lenz, HJ
    Tanaka, MS
    Abbruzzese, JL
    INVESTIGATIONAL NEW DRUGS, 2006, 24 (04) : 335 - 341
  • [4] Phase II trial of R115777 (NSC #70818) in patients with advanced colorectal cancer: A Southwest Oncology Group study
    Robert P. Whitehead
    Sheryl McCoy
    John S. Macdonald
    Saul E. Rivkin
    Marcus A. Neubauer
    Shaker R. Dakhil
    Heinz-Josef Lenz
    Michael S. Tanaka
    James L. Abbruzzese
    Investigational New Drugs, 2006, 24 : 335 - 341
  • [5] Trial in progress: A phase 2 study of CTX-009 in adult patients with metastatic colorectal cancer who have received two or three prior systemic chemotherapy regimens.
    Fontaine, Marilyn
    Pilgrim, Sarah
    Schuetz, Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : TPS281 - TPS281
  • [6] A phase II trial of epothilone B analogue BMS-247550 (NSC #710428) in patients with advanced pancreas cancer: A Southwest Oncology Group Study.
    Whitehead, RP
    McCoy, SA
    Rivkin, SE
    Gross, HM
    Conrad, ME
    Abbruzzese, JL
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 316S - 316S
  • [7] A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202
    Syma Iqbal
    Cathryn Rankin
    Heinz-Josef Lenz
    Philip J. Gold
    Syed A. Ahmad
    Anthony B. El-Khoueiry
    Michael J. Messino
    Randall F. Holcombe
    Charles D. Blanke
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 1595 - 1602
  • [8] A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202
    Iqbal, Syma
    Rankin, Cathryn
    Lenz, Heinz-Josef
    Gold, Philip J.
    Ahmad, Syed A.
    El-Khoueiry, Anthony B.
    Messino, Michael J.
    Holcombe, Randall F.
    Blanke, Charles D.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (06) : 1595 - 1602
  • [9] A phase II trial of oxaliplatin and docetaxel in patients with androgen independent prostate cancer (AIPC) who have progressed to two prior regimens of chemotherapy
    Feinstein, T.
    Appleman, L. J.
    Friedland, D. M.
    Jacobs, S. A.
    Ferri, W. A.
    Earle, M. F.
    Hyoung, K. D.
    Strausser, H.
    Corgnati, S.
    Chatta, G. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] Efficacy update of Nivolumab monotherapy in patients with metastatic or surgically unresectable locally advanced urothelial carcinoma who have received prior platinum-based treatment: phase II CheckMate 275 study
    Bedke, J.
    Sharma, P.
    Retz, M.
    Siefker-Radtke, A.
    Baron, A.
    Necchi, A.
    Plimack, E. R.
    Vaena, D.
    Grimm, M. -O.
    Bracarda, S.
    Arranz, J. A.
    Pal, S.
    Ohyama, C.
    Grullich, C.
    von Amsberg, G.
    Steiner, T.
    Saci, A.
    Lambert, A.
    Azrilevich, A.
    Galsky, M. D.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 114 - +
12345